Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045
|Recently, we connected with Dr. Chong Kim (CK), who received his PhD in Pharmaceutical Outcomes during the fall 2020 Commencement on Dec. 12. Dr. Kim describes himself as a critical thinking, highly motivated, and hard working problem solver. Currently, his specific interests lie in optimizing the landscape of the healthcare environment around the world. His main expertise involves observational studies, development of statistical methods, and programming. He's currently working as a manager at Stratevi.|
Robert Page, PharmD, weighs in on the need for well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease, based on evidence from preclinical studies showing that it has anti-inflammatory effects.
Dr. Gina Moore, PharmD, MBA, talks with Health on why this viral TikTok trend is a dangerous misuse of medication.
A new study from Molly, Huntsman, PhD, suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.
CU Pharmacy and Cancer Center researcher Dmitri Simberg, PhD, is focusing on penetrating the blood-brain barrier in glioblastoma to more effectively deliver anti-cancer therapies.